FDA Clearance Tracker · P050051-S006
ARCHITECT AUSAB
Last checked: Nov 20, 2026Latest source record: Jul 20, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jul 20, 2011
Approved
Time to decision
261 days
Received Nov 1, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class II
The decision
- FDA number
- P050051-S006
- Device name
- ARCHITECT AUSAB
- Applicant
- Abbott Laboratories, Inc.
- Applicant location
- Abbott Park, IL
- Received
- Nov 1, 2010
- Decided
- Jul 20, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P050051
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3172
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT FLEXTRONICS MANUFACTURING (S) PTE. LTD. IN SINGAPORE.
Source documents
Other decisions for Abbott Laboratories, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.